These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10767686)

  • 1. Development of pemphigus vulgaris in a patient with pemphigus foliaceus: antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay.
    Ishii K; Amagai M; Ohata Y; Shimizu H; Hashimoto T; Ohya K; Nishikawa T
    J Am Acad Dermatol; 2000 May; 42(5 Pt 2):859-61. PubMed ID: 10767686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.
    Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris.
    Harman KE; Gratian MJ; Shirlaw PJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2002 Apr; 146(4):684-7. PubMed ID: 11966706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay.
    Komai A; Amagai M; Ishii K; Nishikawa T; Chorzelski T; Matsuo I; Hashimoto T
    Br J Dermatol; 2001 Jun; 144(6):1177-82. PubMed ID: 11422038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.
    Amagai M; Komai A; Hashimoto T; Shirakata Y; Hashimoto K; Yamada T; Kitajima Y; Ohya K; Iwanami H; Nishikawa T
    Br J Dermatol; 1999 Feb; 140(2):351-7. PubMed ID: 10233237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype.
    Harman KE; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2000 Aug; 143(2):343-8. PubMed ID: 10951143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of sensitivity and specificity of enzyme-linked immunosorbent assay (ELISA) for detecting antidesmoglein 1 and 3 in Thai patients with pemphigus vulgaris and foliaceus.
    Kulkollakarn S; Wattanakrai P; Vachiramon V; Chalidapongse P
    J Med Assoc Thai; 2008 Nov; 91(11):1663-8. PubMed ID: 19127786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies.
    Hacker MK; Janson M; Fairley JA; Lin MS
    Clin Immunol; 2002 Oct; 105(1):64-74. PubMed ID: 12483995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3.
    Cheng SW; Kobayashi M; Kinoshita-Kuroda K; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2002 Aug; 147(2):261-5. PubMed ID: 12174096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.
    Harman KE; Seed PT; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2001 Apr; 144(4):775-80. PubMed ID: 11298536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five Japanese cases of antidesmoglein 1 antibody-positive and antidesmoglein 3 antibody-negative pemphigus with oral lesions.
    Koga H; Ohyama B; Tsuruta D; Ishii N; Hamada T; Dainichi T; Natsuaki Y; Sogame R; Fukuda S; Karashima T; Tada J; Yamashiro M; Uezato H; Chan PT; Hashimoto T
    Br J Dermatol; 2012 May; 166(5):976-80. PubMed ID: 22242828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus.
    Futei Y; Amagai M; Ishii K; Kuroda-Kinoshita K; Ohya K; Nishikawa T
    J Dermatol Sci; 2001 May; 26(1):55-61. PubMed ID: 11323221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil.
    Oliveira LA; Marquart-Filho A; Trevilato G; Timoteo RP; Mukai M; Roselino AM; Petzl-Erler ML
    Clin Lab; 2016 Jul; 62(7):1209-1216. PubMed ID: 28164651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG/IgA pemphigus with IgG and IgA antidesmoglein 1 antibodies detected by enzyme-linked immunosorbent assay.
    Oiso N; Yamashita C; Yoshioka K; Amagai M; Komai A; Nagata Y; Hashimoto T; Ishii M
    Br J Dermatol; 2002 Nov; 147(5):1012-7. PubMed ID: 12410717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of IgA autoantibodies to desmogleins by an enzyme-linked immunosorbent assay: the presence of new minor subtypes of IgA pemphigus.
    Hashimoto T; Komai A; Futei Y; Nishikawa T; Amagai M
    Arch Dermatol; 2001 Jun; 137(6):735-8. PubMed ID: 11405762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein-3 and desmoglein-1.
    Lin MS; Swartz SJ; Lopez A; Ding X; Fairley JA; Diaz LA
    J Invest Dermatol; 1997 Dec; 109(6):734-7. PubMed ID: 9406813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages.
    Kamiya K; Aoyama Y; Yamasaki O; Kamata A; Yamagami J; Iwatsuki K; Tokura Y
    Br J Dermatol; 2016 Jan; 174(1):113-9. PubMed ID: 26294113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
    Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C
    J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.